US Stock MarketDetailed Quotes

IONS Ionis Pharmaceuticals

Watchlist
  • 31.040
  • +0.690+2.27%
Close Feb 14 16:00 ET
  • 31.040
  • 0.0000.00%
Post 20:01 ET
4.90BMarket Cap-12.72P/E (TTM)

Ionis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ionis Pharmaceuticals Q4 2024 Estimates Date

Currency：USDFeb 19, 2025

Estimate YoY
Revenue
140.95M
-56.63%
EPS
-1.13
-1785.64%
Analyst Rating
Buy

Feb 17, 2025

Ionis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 131.138M--
Feb 19, 20252024/Q4-- / 140.949M--
Nov 6, 20242024/Q3134.000M / 129.926M--
Aug 1, 20242024/Q2225.000M / 149.794M--
May 7, 20242024/Q1119.000M / 136.411M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 131.138M--
Feb 19, 20252024/Q4-- / 140.949M--
Nov 6, 20242024/Q3134.000M / 129.926M--
Aug 1, 20242024/Q2225.000M / 149.794M--
May 7, 20242024/Q1119.000M / 136.411M--

Unlock Free Earnings Estimates

Ionis Pharmaceuticals Earnings Reports

  • Ionis Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:15 ET

  • Ionis Pharmaceuticals | 8-K: Ionis reports third quarter 2024 financial results

    Nov 6, 2024 11:17 ET

  • Ionis Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 17:03 ET

  • Ionis Pharmaceuticals | 8-K: Ionis reports second quarter 2024 financial results

    Aug 1, 2024 11:16 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 17, 2025

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data